Invesco Ltd. Dbv Technologies S.A. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.33 - $12.98 $750,027 - $4.18 Million	-321,900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.75 - $11.15 $12,825 - $21,185	-1,900 Reduced 0.59%	321,900 $3.44 Million
Q3 2019 Nov 14, 2019	SELL	$8.57 - $10.72 $4.06 Million - $5.08 Million	-473,617 Reduced 59.39%	323,800 $2.79 Million
Q4 2018 Feb 14, 2019	BUY	$5.75 - $21.85 $4.59 Million - $17.4 Million	797,417 New	797,417 $5.12 Million

253K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $124M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.